DOI:
10.1055/s-00000022
Das Gesundheitswesen
LinksClose Window
References
Johnson FR, Van Houtven G, Ozdemir S et al.
Multiple sclerosis patients’ benefit-risk preferences: serious adverse event risks versus treatment efficacy.
J Neurol 2009;
256: 554-562
DOI: 10.1007/s00415-009-0084-2.
We do not assume any responsibility for the contents of the web pages of other providers.